News - Page 210 - Psychedelic Alpha

Our 🎯 Q1 2026 Psychedelic Pipeline Bullseye Charts are now available.

Read more about the article Psychedelic Bulletin: California Bill Aims to Decriminalize Psychedelics; MindMed Acquires HealthMode; and more…

Psychedelic Bulletin: California Bill Aims to Decriminalize Psychedelics; MindMed Acquires HealthMode; and more…

Post published:February 19, 2021
Post category:Psychedelic Bulletin

Read more about the article Algernon Pharmaceuticals Awards DMT Manufacturing Contract to Dalton Pharma for Stroke Program

Algernon Pharmaceuticals Awards DMT Manufacturing Contract to Dalton Pharma for Stroke Program

Post published:February 19, 2021
Post category:Press Release

Read more about the article Silo Pharma Licenses Novel Peptide-Guided Drug Delivery Approach for the Treatment of MS

Silo Pharma Licenses Novel Peptide-Guided Drug Delivery Approach for the Treatment of MS

Post published:February 18, 2021
Post category:Press Release

Read more about the article Lobe Sciences Successfully Completes Proof-of-Concept of Proprietary Nasal Mist Device

Lobe Sciences Successfully Completes Proof-of-Concept of Proprietary Nasal Mist Device

Post published:February 18, 2021
Post category:Press Release

Read more about the article Red Light Holland Receives Receipt for Final Short-form Prospectus for Previously Announced $10 Million Bought Deal Public Offering

Red Light Holland Receives Receipt for Final Short-form Prospectus for Previously Announced $10 Million Bought Deal Public Offering

Post published:February 18, 2021
Post category:Press Release

Numinus announces milestones in compassionate access trial for MDMA-assisted therapy in collaboration with MAPS Public Benefit Corporation

Post published:February 18, 2021
Post category:Press Release

Read more about the article MindMed Reaches Agreement to Acquire HealthMode, a Leading Machine Learning Digital Medicine Company

MindMed Reaches Agreement to Acquire HealthMode, a Leading Machine Learning Digital Medicine Company

Post published:February 18, 2021
Post category:Press Release

Read more about the article MINDCURE Announces Official Release of Nootropic and Adaptogen Products, Available on E-Commerce Platform

MINDCURE Announces Official Release of Nootropic and Adaptogen Products, Available on E-Commerce Platform

Post published:February 18, 2021
Post category:Press Release

Read more about the article Nova Mentis Expands Pre-Clinical Development Pipeline; Company Begins Fragile X Syndrome Treatment with its Proprietary Psilocybin Drug

Nova Mentis Expands Pre-Clinical Development Pipeline; Company Begins Fragile X Syndrome Treatment with its Proprietary Psilocybin Drug

Post published:February 18, 2021
Post category:Press Release

Read more about the article Champignon Brands to Restate Financial Statements and MD&A has Prepared CSE Listing Statement

Champignon Brands to Restate Financial Statements and MD&A has Prepared CSE Listing Statement

Post published:February 17, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond. Psy Alpha Ltd is a company registered in England and Wales (16989109).

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.